Sagefield Capital LP Taro Pharmaceutical Industries LTD Transaction History
Sagefield Capital LP
- $769 Million
- Q1 2024
A detailed history of Sagefield Capital LP transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Sagefield Capital LP holds 15,700 shares of TARO stock, worth $0. This represents 0.09% of its overall portfolio holdings.
Number of Shares
15,700Holding current value
$0% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding TARO
# of Institutions
93Shares Held
4.64MCall Options Held
7KPut Options Held
6.3K-
Krensavage Asset Management, LLC New York, NY648KShares$012.16% of portfolio
-
Black Rock Inc. New York, NY616KShares$00.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny571KShares$00.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX520KShares$00.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA284KShares$00.16% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...